Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 100 entries
Sorted by: Best Match Show Resources per page
Hyperuricemia and non-dipping blood pressure.

International journal of nephrology and renovascular disease

Marrone O, Bonsignore MR.
PMID: 24348063
Int J Nephrol Renovasc Dis. 2013 Dec 04;6:269-70. doi: 10.2147/IJNRD.S55750. eCollection 2013.

No abstract available.

Cite
Marrone O, Bonsignore MR. Hyperuricemia and non-dipping blood pressure. Int J Nephrol Renovasc Dis. 2013;6:269-70doi: 10.2147/IJNRD.S55750.
Marrone, O., & Bonsignore, M. R. (2013). Hyperuricemia and non-dipping blood pressure. International journal of nephrology and renovascular disease, 6269-70. https://doi.org/10.2147/IJNRD.S55750
Marrone, Oreste, and Bonsignore, Maria Rosaria. "Hyperuricemia and non-dipping blood pressure." International journal of nephrology and renovascular disease vol. 6 (2013): 269-70. doi: https://doi.org/10.2147/IJNRD.S55750
Marrone O, Bonsignore MR. Hyperuricemia and non-dipping blood pressure. Int J Nephrol Renovasc Dis. 2013 Dec 04;6:269-70. doi: 10.2147/IJNRD.S55750. eCollection 2013. PMID: 24348063; PMCID: PMC3857262.
Copy Download .nbib Format: NLM
Metabolism of human erythrocyte glucose-6-phosphate dehydrogenase. III - isolation of a protein involved in the 6-phosphogluconate-induced inactivation.

FEBS letters

Bonsignore A, De Flora A, Lorenzoni I, Mangiarotti MA, Cancedda R, Dina D.
PMID: 11945287
FEBS Lett. 1968 Aug;1(3):176-178. doi: 10.1016/0014-5793(68)80053-5.

No abstract available.

Cite
Bonsignore A, De Flora A, Lorenzoni I, et al. Metabolism of human erythrocyte glucose-6-phosphate dehydrogenase. III - isolation of a protein involved in the 6-phosphogluconate-induced inactivation. FEBS Lett. 1968;1(3):176-178doi: 10.1016/0014-5793(68)80053-5.
Bonsignore, A., De Flora, A., Lorenzoni, I., Mangiarotti, M. A., Cancedda, R., & Dina, D. (1968). Metabolism of human erythrocyte glucose-6-phosphate dehydrogenase. III - isolation of a protein involved in the 6-phosphogluconate-induced inactivation. FEBS letters, 1(3), 176-178. https://doi.org/10.1016/0014-5793(68)80053-5
Bonsignore, A, et al. "Metabolism of human erythrocyte glucose-6-phosphate dehydrogenase. III - isolation of a protein involved in the 6-phosphogluconate-induced inactivation." FEBS letters vol. 1,3 (1968): 176-178. doi: https://doi.org/10.1016/0014-5793(68)80053-5
Bonsignore A, De Flora A, Lorenzoni I, Mangiarotti MA, Cancedda R, Dina D. Metabolism of human erythrocyte glucose-6-phosphate dehydrogenase. III - isolation of a protein involved in the 6-phosphogluconate-induced inactivation. FEBS Lett. 1968 Aug;1(3):176-178. doi: 10.1016/0014-5793(68)80053-5. PMID: 11945287.
Copy Download .nbib Format: NLM
Myocardial ischemia during sleep.

Sleep medicine reviews

Bonsignore MR, Smirne S, Marrone O, Insalaco G, Salvaggio A, Bonsignore G.
PMID: 15310478
Sleep Med Rev. 1999 Sep;3(3):241-55. doi: 10.1016/s1087-0792(99)90005-9.

The role of sleep in the pathogenesis of coronary ischaemic events such as myocardial infarction, transient myocardial ischaemia, or cardiac sudden death, is unclear. This review will analyse the available data on the subject according to: (i) the autonomic...

Cite
Bonsignore MR, Smirne S, Marrone O, et al. Myocardial ischemia during sleep. Sleep Med Rev. 1999;3(3):241-55doi: 10.1016/s1087-0792(99)90005-9.
Bonsignore, M. R., Smirne, S., Marrone, O., Insalaco, G., Salvaggio, A., & Bonsignore, G. (1999). Myocardial ischemia during sleep. Sleep medicine reviews, 3(3), 241-55. https://doi.org/10.1016/s1087-0792(99)90005-9
Bonsignore, M R, et al. "Myocardial ischemia during sleep." Sleep medicine reviews vol. 3,3 (1999): 241-55. doi: https://doi.org/10.1016/s1087-0792(99)90005-9
Bonsignore MR, Smirne S, Marrone O, Insalaco G, Salvaggio A, Bonsignore G. Myocardial ischemia during sleep. Sleep Med Rev. 1999 Sep;3(3):241-55. doi: 10.1016/s1087-0792(99)90005-9. PMID: 15310478.
Copy Download .nbib Format: NLM
Liposome-incorporated santolina insularis essential oil: preparation, characterization and in vitro antiviral activity.

Journal of liposome research

Valenti D, De Logu A, Loy G, Sinico C, Bonsignore L, Cottiglia F, Garau D, Fadda AM.
PMID: 19530920
J Liposome Res. 2001;11(1):73-90. doi: 10.1081/LPR-100103171.

The effect of liposomal inclusion on the stability and in vitro antiherpetic activity of Santolina insularis essential oil was investigated. In order to study the influence of vesicle structure on the liposome properties, multilamellar and unilamellar vesicles were prepared...

Cite
Valenti D, De Logu A, Loy G, et al. Liposome-incorporated santolina insularis essential oil: preparation, characterization and in vitro antiviral activity. J Liposome Res. 2001;11(1):73-90doi: 10.1081/LPR-100103171.
Valenti, D., De Logu, A., Loy, G., Sinico, C., Bonsignore, L., Cottiglia, F., Garau, D., & Fadda, A. M. (2001). Liposome-incorporated santolina insularis essential oil: preparation, characterization and in vitro antiviral activity. Journal of liposome research, 11(1), 73-90. https://doi.org/10.1081/LPR-100103171
Valenti, D, et al. "Liposome-incorporated santolina insularis essential oil: preparation, characterization and in vitro antiviral activity." Journal of liposome research vol. 11,1 (2001): 73-90. doi: https://doi.org/10.1081/LPR-100103171
Valenti D, De Logu A, Loy G, Sinico C, Bonsignore L, Cottiglia F, Garau D, Fadda AM. Liposome-incorporated santolina insularis essential oil: preparation, characterization and in vitro antiviral activity. J Liposome Res. 2001;11(1):73-90. doi: 10.1081/LPR-100103171. PMID: 19530920.
Copy Download .nbib Format: NLM
Acceptance tests of diagnostic displays in a PACS system according to AAPM TG18.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Cresp A, Bonsignore F, Paruccini N, De Ponti E, Macchi I.
PMID: 17664151
Phys Med. 2006 January - March;22(1):17-24. doi: 10.1016/S1120-1797(06)80006-2.

In a filmless environment it is necessary to execute acceptance and constancy tests on monitors used for interpretation of medical images. Performances of Barco CRT MGD521 MKII, Barco LCD L685EX monitors have been evaluated. Acceptancepress were executed following AAPM...

Cite
Cresp A, Bonsignore F, Paruccini N, et al. Acceptance tests of diagnostic displays in a PACS system according to AAPM TG18. Phys Med. 2006;22(1):17-24doi: 10.1016/S1120-1797(06)80006-2.
Cresp, A., Bonsignore, F., Paruccini, N., De Ponti, E., & Macchi, I. (2006). Acceptance tests of diagnostic displays in a PACS system according to AAPM TG18. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 22(1), 17-24. https://doi.org/10.1016/S1120-1797(06)80006-2
Cresp, Andrea, et al. "Acceptance tests of diagnostic displays in a PACS system according to AAPM TG18." Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) vol. 22,1 (2006): 17-24. doi: https://doi.org/10.1016/S1120-1797(06)80006-2
Cresp A, Bonsignore F, Paruccini N, De Ponti E, Macchi I. Acceptance tests of diagnostic displays in a PACS system according to AAPM TG18. Phys Med. 2006 January - March;22(1):17-24. doi: 10.1016/S1120-1797(06)80006-2. PMID: 17664151.
Copy Download .nbib Format: NLM
Decays of 118In, 120In isomers to levels in 118Sn, 120Sn, and 122Sn.

Physical review. C, Nuclear physics

Allaart K, Bonsignori G, Multhauf LG, Raman S, Tirsell KG, Walkiewicz TA.
PMID: 9954559
Phys Rev C Nucl Phys. 1988 Mar;37(3):1203-1228. doi: 10.1103/physrevc.37.1203.

No abstract available.

Cite
Allaart K, Bonsignori G, Multhauf LG, et al. Decays of 118In, 120In isomers to levels in 118Sn, 120Sn, and 122Sn. Phys Rev C Nucl Phys. 1988;37(3):1203-1228doi: 10.1103/physrevc.37.1203.
Allaart, K., Bonsignori, G., Multhauf, L. G., Raman, S., Tirsell, K. G., & Walkiewicz, T. A. (1988). Decays of 118In, 120In isomers to levels in 118Sn, 120Sn, and 122Sn. Physical review. C, Nuclear physics, 37(3), 1203-1228. https://doi.org/10.1103/physrevc.37.1203
Allaart, et al. "Decays of 118In, 120In isomers to levels in 118Sn, 120Sn, and 122Sn." Physical review. C, Nuclear physics vol. 37,3 (1988): 1203-1228. doi: https://doi.org/10.1103/physrevc.37.1203
Allaart K, Bonsignori G, Multhauf LG, Raman S, Tirsell KG, Walkiewicz TA. Decays of 118In, 120In isomers to levels in 118Sn, 120Sn, and 122Sn. Phys Rev C Nucl Phys. 1988 Mar;37(3):1203-1228. doi: 10.1103/physrevc.37.1203. PMID: 9954559.
Copy Download .nbib Format: NLM
Two-quasiparticle states in the interacting boson model. II. Electromagnetic properties in the SU(3) limit.

Physical review. C, Nuclear physics

Bonsignori G, Paar V, Savoia M, Vretenar D.
PMID: 9967393
Phys Rev C Nucl Phys. 1991 Jul;44(1):223-232. doi: 10.1103/physrevc.44.223.

No abstract available.

Cite
Bonsignori G, Paar V, Savoia M, et al. Two-quasiparticle states in the interacting boson model. II. Electromagnetic properties in the SU(3) limit. Phys Rev C Nucl Phys. 1991;44(1):223-232doi: 10.1103/physrevc.44.223.
Bonsignori, G., Paar, V., Savoia, M., & Vretenar, D. (1991). Two-quasiparticle states in the interacting boson model. II. Electromagnetic properties in the SU(3) limit. Physical review. C, Nuclear physics, 44(1), 223-232. https://doi.org/10.1103/physrevc.44.223
Bonsignori, et al. "Two-quasiparticle states in the interacting boson model. II. Electromagnetic properties in the SU(3) limit." Physical review. C, Nuclear physics vol. 44,1 (1991): 223-232. doi: https://doi.org/10.1103/physrevc.44.223
Bonsignori G, Paar V, Savoia M, Vretenar D. Two-quasiparticle states in the interacting boson model. II. Electromagnetic properties in the SU(3) limit. Phys Rev C Nucl Phys. 1991 Jul;44(1):223-232. doi: 10.1103/physrevc.44.223. PMID: 9967393.
Copy Download .nbib Format: NLM
De novo mutation in .

Journal of neurogenetics

Nicotera AG, Dicanio D, Pironti E, Bonsignore M, Cafeo A, Efthymiou S, Mondello P, Salpietro V, Houlden H, Di Rosa G.
PMID: 33821742
J Neurogenet. 2021 Mar-Jun;35(2):67-73. doi: 10.1080/01677063.2021.1892094. Epub 2021 Apr 06.

The

Cite
Nicotera AG, Dicanio D, Pironti E, et al. De novo mutation in . J Neurogenet. 2021;35(2):67-73doi: 10.1080/01677063.2021.1892094.
Nicotera, A. G., Dicanio, D., Pironti, E., Bonsignore, M., Cafeo, A., Efthymiou, S., Mondello, P., Salpietro, V., Houlden, H., & Di Rosa, G. (2021). De novo mutation in . Journal of neurogenetics, 35(2), 67-73. https://doi.org/10.1080/01677063.2021.1892094
Nicotera, Antonio Gennaro, et al. "De novo mutation in ." Journal of neurogenetics vol. 35,2 (2021): 67-73. doi: https://doi.org/10.1080/01677063.2021.1892094
Nicotera AG, Dicanio D, Pironti E, Bonsignore M, Cafeo A, Efthymiou S, Mondello P, Salpietro V, Houlden H, Di Rosa G. De novo mutation in . J Neurogenet. 2021 Mar-Jun;35(2):67-73. doi: 10.1080/01677063.2021.1892094. Epub 2021 Apr 06. PMID: 33821742.
Copy Download .nbib Format: NLM
Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy.

JACC. CardioOncology

Bonsignore A, Marwick TH, Adams SC, Thampinathan B, Somerset E, Amir E, Walker M, Abdel-Qadir H, Koch CA, Ross HJ, Woo A, Wintersperger BJ, Haykowsky MJ, Thavendiranathan P.
PMID: 34988476
JACC CardioOncol. 2021 Nov 16;3(5):678-691. doi: 10.1016/j.jaccao.2021.08.010. eCollection 2021 Dec.

BACKGROUND: Cardiorespiratory fitness (CRF) is reduced in cancer survivors and predicts cardiovascular disease (CVD)-related and all-cause mortality. However, routine measurement of CRF is not always feasible.OBJECTIVES: The purpose of this study was to identify clinical, cardiac biomarker, and imaging...

Cite
Bonsignore A, Marwick TH, Adams SC, et al. Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy. JACC CardioOncol. 2021;3(5):678-691doi: 10.1016/j.jaccao.2021.08.010.
Bonsignore, A., Marwick, T. H., Adams, S. C., Thampinathan, B., Somerset, E., Amir, E., Walker, M., Abdel-Qadir, H., Koch, C. A., Ross, H. J., Woo, A., Wintersperger, B. J., Haykowsky, M. J., & Thavendiranathan, P. (2021). Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy. JACC. CardioOncology, 3(5), 678-691. https://doi.org/10.1016/j.jaccao.2021.08.010
Bonsignore, Alis, et al. "Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy." JACC. CardioOncology vol. 3,5 (2021): 678-691. doi: https://doi.org/10.1016/j.jaccao.2021.08.010
Bonsignore A, Marwick TH, Adams SC, Thampinathan B, Somerset E, Amir E, Walker M, Abdel-Qadir H, Koch CA, Ross HJ, Woo A, Wintersperger BJ, Haykowsky MJ, Thavendiranathan P. Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy. JACC CardioOncol. 2021 Nov 16;3(5):678-691. doi: 10.1016/j.jaccao.2021.08.010. eCollection 2021 Dec. PMID: 34988476; PMCID: PMC8702792.
Copy Download .nbib Format: NLM
Obesity and Obstructive Sleep Apnea.

Handbook of experimental pharmacology

Bonsignore MR.
PMID: 34697666
Handb Exp Pharmacol. 2021 Oct 26; doi: 10.1007/164_2021_558. Epub 2021 Oct 26.

Obstructive sleep apnea (OSA) is characterized by upper airway collapse during sleep. Chronic intermittent hypoxia, sleep fragmentation, and inflammatory activation are the main pathophysiological mechanisms of OSA. OSA is highly prevalent in obese patients and may contribute to cardiometabolic...

Cite
Bonsignore MR. Obesity and Obstructive Sleep Apnea. Handb Exp Pharmacol. 2021;doi: 10.1007/164_2021_558.
Bonsignore, M. R. (2021). Obesity and Obstructive Sleep Apnea. Handbook of experimental pharmacology, . https://doi.org/10.1007/164_2021_558
Bonsignore, Maria R. "Obesity and Obstructive Sleep Apnea." Handbook of experimental pharmacology vol. (2021). doi: https://doi.org/10.1007/164_2021_558
Bonsignore MR. Obesity and Obstructive Sleep Apnea. Handb Exp Pharmacol. 2021 Oct 26; doi: 10.1007/164_2021_558. Epub 2021 Oct 26. PMID: 34697666.
Copy Download .nbib Format: NLM
Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region.

Journal of clinical medicine

Vena A, Cenderello G, Balletto E, Mezzogori L, Santagostino Barbone A, Berruti M, Ball L, Battaglini D, Bonsignore A, Dentone C, Giacobbe DR, Eldin TK, Mikulska M, Rebesco B, Robba C, Scintu A, Stimamiglio A, Taramasso L, Pelosi P, Artioli S, Bassetti M.
PMID: 34682805
J Clin Med. 2021 Oct 13;10(20). doi: 10.3390/jcm10204682.

Monoclonal antibodies, such as bamlanivimab and etesevimab combination (BEC), have been proposed for patients with mild or moderate coronavirus disease 2019 (COVID-19). However, few studies have assessed the factors associated with the early administration of BEC or the impact...

Cite
Vena A, Cenderello G, Balletto E, et al. Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region. J Clin Med. 2021;10(20)doi: 10.3390/jcm10204682.
Vena, A., Cenderello, G., Balletto, E., Mezzogori, L., Santagostino Barbone, A., Berruti, M., Ball, L., Battaglini, D., Bonsignore, A., Dentone, C., Giacobbe, D. R., Eldin, T. K., Mikulska, M., Rebesco, B., Robba, C., Scintu, A., Stimamiglio, A., Taramasso, L., Pelosi, P., Artioli, S., & Bassetti, M. (2021). Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region. Journal of clinical medicine, 10(20), . https://doi.org/10.3390/jcm10204682
Vena, Antonio, et al. "Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region." Journal of clinical medicine vol. 10,20 (2021). doi: https://doi.org/10.3390/jcm10204682
Vena A, Cenderello G, Balletto E, Mezzogori L, Santagostino Barbone A, Berruti M, Ball L, Battaglini D, Bonsignore A, Dentone C, Giacobbe DR, Eldin TK, Mikulska M, Rebesco B, Robba C, Scintu A, Stimamiglio A, Taramasso L, Pelosi P, Artioli S, Bassetti M. Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region. J Clin Med. 2021 Oct 13;10(20). doi: 10.3390/jcm10204682. PMID: 34682805; PMCID: PMC8538905.
Copy Download .nbib Format: NLM
Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.

PLoS pathogens

LaBranche CC, Henderson R, Hsu A, Behrens S, Chen X, Zhou T, Wiehe K, Saunders KO, Alam SM, Bonsignori M, Borgnia MJ, Sattentau QJ, Eaton A, Greene K, Gao H, Liao HX, Williams WB, Peacock J, Tang H, Perez LG, Edwards RJ, Kepler TB, Korber BT, Kwong PD, Mascola JR, Acharya P, Haynes BF, Montefiori DC.
PMID: 31790514
PLoS Pathog. 2019 Dec 02;15(12):e1008200. doi: 10.1371/journal.ppat.1008200. eCollection 2019 Dec.

[This corrects the article DOI: 10.1371/journal.ppat.1008026.].

Cite
LaBranche CC, Henderson R, Hsu A, et al. Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies. PLoS Pathog. 2019;15(12):e1008200doi: 10.1371/journal.ppat.1008200.
LaBranche, C. C., Henderson, R., Hsu, A., Behrens, S., Chen, X., Zhou, T., Wiehe, K., Saunders, K. O., Alam, S. M., Bonsignori, M., Borgnia, M. J., Sattentau, Q. J., Eaton, A., Greene, K., Gao, H., Liao, H. X., Williams, W. B., Peacock, J., Tang, H., Perez, L. G., Edwards, R. J., Kepler, T. B., Korber, B. T., Kwong, P. D., Mascola, J. R., Acharya, P., Haynes, B. F., & Montefiori, D. C. (2019). Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies. PLoS pathogens, 15(12), e1008200. https://doi.org/10.1371/journal.ppat.1008200
LaBranche, Celia C, et al. "Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies." PLoS pathogens vol. 15,12 (2019): e1008200. doi: https://doi.org/10.1371/journal.ppat.1008200
LaBranche CC, Henderson R, Hsu A, Behrens S, Chen X, Zhou T, Wiehe K, Saunders KO, Alam SM, Bonsignori M, Borgnia MJ, Sattentau QJ, Eaton A, Greene K, Gao H, Liao HX, Williams WB, Peacock J, Tang H, Perez LG, Edwards RJ, Kepler TB, Korber BT, Kwong PD, Mascola JR, Acharya P, Haynes BF, Montefiori DC. Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies. PLoS Pathog. 2019 Dec 02;15(12):e1008200. doi: 10.1371/journal.ppat.1008200. eCollection 2019 Dec. PMID: 31790514; PMCID: PMC6886749.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 100 entries